128 related articles for article (PubMed ID: 29120572)
21. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients.
Sghaier I; Mouelhi L; Rabia NA; Alsaleh BR; Ghazoueni E; Almawi WY; Loueslati BY
Cytokine; 2017 Jan; 89():62-67. PubMed ID: 28340949
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
[TBL] [Abstract][Full Text] [Related]
23. Association Between Polymorphisms of Interleukin 1 Family Genes and Hepatocellular Carcinoma.
Tak KH; Yu GI; Lee MY; Shin DH
Med Sci Monit; 2018 May; 24():3488-3495. PubMed ID: 29802240
[TBL] [Abstract][Full Text] [Related]
24. [Association of MMP3 promoter 5A/6A polymorphism with stability of extracellular matrix of atherosclerotic plaque].
Du J; Liu Y; Gao J; Chen S; Jiang H; Zhao L; Cong H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jun; 36(6):645-648. PubMed ID: 31055827
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis B and C viruses.
El Samanoudy A; Monir R; Badawy A; Ibrahim L; Farag K; El Baz S; Alenizi D; Alenezy A
Genet Mol Res; 2014 Sep; 13(3):8025-34. PubMed ID: 25299117
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
Alsalawy NF; Darwish RK; Kamal MM; ElTaweel AE; Shousha HI; Elbaz TM
J Med Virol; 2018 Mar; 90(3):490-496. PubMed ID: 28975649
[TBL] [Abstract][Full Text] [Related]
27. Association of Interleukin-8 Gene Polymorphisms and Expression with Hepatocellular Carcinoma in Egyptian Patients with Liver Cirrhosis.
Hassanin OM; El-Masry TM; El-Baz A; Adel-Abou-Zaghla HM
Egypt J Immunol; 2017 Jan; 24(1):143-152. PubMed ID: 29120586
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma.
Agúndez JA; García-Martín E; Devesa MJ; Carballo M; Martínez C; Lee-Brunner A; Fernández C; Díaz-Rubio M; Ladero JM
Oncology; 2012; 82(1):35-40. PubMed ID: 22286521
[TBL] [Abstract][Full Text] [Related]
30. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
[TBL] [Abstract][Full Text] [Related]
31. Association of XRCC1 p. Arg194Trp gene polymorphism with the risk of hepatocellular carcinoma in HCV Egyptian population: A pilot case-control study.
Ghorab RA; Fouad SH; Elsaadawy Y; Hamdy M; Taha SI
Int J Immunopathol Pharmacol; 2024; 38():3946320241265263. PubMed ID: 38898405
[No Abstract] [Full Text] [Related]
32. The association of the metalloproteinase-3 gene promoter polymorphisms and the middle cerebral artery stenosis.
Fu C; Xing Y; Song X
Cell Biochem Biophys; 2011 Apr; 59(3):185-9. PubMed ID: 21113741
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
[TBL] [Abstract][Full Text] [Related]
34. Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
Saad H; Zahran MA; Hendy O; Abdel-Samiee M; Bedair HM; Abdelsameea E
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3725-3734. PubMed ID: 33369474
[TBL] [Abstract][Full Text] [Related]
35. The association between interleukin-21 (rs2055979G/T) gene polymorphism and the risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus.
Bakr NM; Awad A; Moustafa EA; El-Gebaly AM
J Cell Biochem; 2019 Oct; 120(10):18524-18532. PubMed ID: 31237020
[TBL] [Abstract][Full Text] [Related]
36. Variation of matrix metalloproteinase 1 and 3 haplotypes and their serum levels in patients with rheumatoid arthritis and osteoarthritis.
Abd-Allah SH; Shalaby SM; Pasha HF; El-Shal AS; Abou El-Saoud AM
Genet Test Mol Biomarkers; 2012 Jan; 16(1):15-20. PubMed ID: 21770773
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
38. MMP3 -1171 5A/6A Promoter Genotype Influences Serum MMP3 Levels and Is Associated with Deep Venous Thrombosis.
Li XP; Wan GZ; Wang GJ; Li JF
Ann Vasc Surg; 2016 Jul; 34():261-7. PubMed ID: 27177702
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.
Zhang C; Li C; Zhu M; Zhang Q; Xie Z; Niu G; Song X; Jin L; Li G; Zheng H
PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955
[TBL] [Abstract][Full Text] [Related]
40. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
Zhang QX; Yao YQ; Li SL; Long Q
Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
